BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201029
DTEND;VALUE=DATE:20201031
DTSTAMP:20260515T122957
CREATED:20200709T091800Z
LAST-MODIFIED:20200709T092312Z
UID:26239-1603929600-1604102399@www.pharmajournalist.com
SUMMARY:Patient-to-Patient Supply for Cell Immunotherapies Summit
DESCRIPTION:Achieving Standardization & Operational Excellence in Vein-to-Vein Supply \nAs an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment\, cell therapies pose unique supply chain challenges. \n \nAt the inaugural Patient-to-Patient Supply for Cell Immunotherapies Summit\, this community will share their expertise and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale. \nFrom time and temperature sensitivity\, to patient-facing service and integrated platforms\, a seamless vein-to-vein supply chain is central in maintaining cell immunotherapy safety and efficacy at scale and maximizing the patient experience. \nJoin the strategic experts from GSK\, bluebird bio\, Adaptimmune\, Celgene\, BMS and more\, to discuss best practice for patient-facing supply chains and build integrated platforms for chain of identity and end-user access.
URL:https://www.pharmajournalist.com/event/patient-to-patient-supply-for-cell-immunotherapies-summit/
LOCATION:Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR